Clinical Trials Logo

Filter by:
  • Withdrawn  
  • « Prev · Page [6]
NCT ID: NCT01157975 Withdrawn - Hepatitis C Clinical Trials

Study the Relationship Between Obesity and Hepatitis C Replication

Start date: October 2008
Phase: Phase 2
Study type: Interventional

Patients with chronic hepatitis C viral infection (HCV) and with a BMI greater than 25Kg/m2 are refractory to medical treatment. Also, HCV replication seems to be affected when modeling insulin resistance in replicon cell culture systems. PPARg -agonist (Pioglitazone) is effective in controlling liver inflammation in obese subjects with non-alcoholic steatohepatitis (NASH) and also improving insulin sensitivity. Therefore, we hypothesize that improving insulin resistance and /or inflammation may affect HCV replication and viral kinetics. Independently of PPARg pathways, Prednisone may increase HCV viral kinetics. .

NCT ID: NCT01121328 Withdrawn - Clinical trials for Respiratory Distress Syndrome

Autologous Umbilical Cord Blood Transfusion for Preterm Neonates

Start date: July 2011
Phase: Phase 1
Study type: Interventional

This is a pilot study to test feasibility of collection, preparation and infusion of a baby's own (autologous) umbilical cord blood in the first 14 days after birth if the baby is born premature <35 weeks of gestation.